Hipoglucemia tumoral dependiente y no dependiente de células β-pancreáticas, un reto diagnóstico

Tumor and non-tumor mediated hypoglycemia by pancreatic beta cells, a diagnostic challenge

La hipoglucemia es una urgencia médica frecuente que en la mayoría de los casos es secundaria al uso de fármacos hipoglucemiantes, orales o inyectados, indicados en pacientes con diabetes mellitus. No obstante, puede presentarse en forma espontánea y severa relacionándose con múltiples condiciones clínicas, incluyendo las neoplasias. Ante una hipoglucemia de origen paraneoplásico se deben reconocer los mecanismos fisiopatológicos que la generan y establecer el diagnóstico oportuno y preciso para disminuir las complicaciones propias de este síndrome clínico. Presentamos dos pacientes con cuadro de hipoglucemia refractaria al manejo médico inicial, de aparición similar con patologías diferentes. El primer caso corresponde a un paciente con insulinoma y el segundo con un hemangiopericitoma.

1. Edridge CL, Dunkley AJ, Bodicoat DH, Rose TC, Gray LJ, Davies MJ, et al. Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLoS One. 2015;10(6):e0126427. doi: 10.1371/journal.pone.0126427
2. Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine. 2016;53(1):47-57. doi: 10.1007/s12020-016-0902-0.
3. Takeishi S, Mori A, Hachiya H, Yumura T, Ito S, Shibuya T, et al. Hypoglycemia and glycemic variability are associated with mortality in non-intensive care unit hospitalized infectious disease patients with diabetes mellitus. J Diabetes Investig. 2016;7(3):429-35. doi: 10.1111/jdi.12436
4. Martens P, Tits J. Approach to the patient with spontaneous hypoglycemia. Eur J Intern Med. 2014;25(5):415-21. doi: 10.1016/j.ejim.2014.02.011
5. Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis. JAMA. 2016;316(3):313-24. doi: 10.1001/jama.2016.9400
6. Iglesias P, Díez JJ. Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur J Endocrinol. 2014;170(4):R147-57. doi: 10.1530/EJE-13-1012
7. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711-9. doi: 10.1016/s0025-6196(12)62083-7
8. Vaidakis D, Karoubalis J, Pappa T, Piaditis G, Zografos GN. Pancreatic insulinoma: current issues and trends. Hepatobiliary Pancreat Dis Int. 2010;9(3):234-41.
9. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15(2):409-27. doi: 10.1677/ERC-07-0221
10. Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin North Am. 2009;89(5):1105-21. doi: 10.1016/j.suc.2009.06.009
11. Garcia-Molina FJ, Franco Osorio JD, Medina Diez J. Retroperitoneal pelvic hemangiopericytoma. Combined abdominoperineal resection. Rev Esp Enferm Dig. 2002;94(9):558-63.
12. Essola B, Remmelink M, Kessler R, Scillia P, Rocmans P. [Primary pulmonary hemangiopericytoma: 2 new cases]. Rev Med Brux. 2003;24(5):408-15.
13. Rosenblatt GS, Walsh CJ, Basile JJ. Pelvic hemangiopericytoma in a patient with mixed germ cell tumor of the testis. J Urol; 166(5):1824-5.
14. Khowaja A, Johnson-Rabbett B, Bantle J, Moheet A. Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review. BMC Endocr Disord. 2014;14:49. doi: 10.1186/1472-6823-14-49
15. Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013;20(6):R321-39. doi: 10.1530/ERC-13-0231.
16. Fama F, Le Bouc Y, Barrande G, Villeneuve A, Berry MG, Pidoto RR, et al. Solitary fibrous tumour of the liver with IGF-II-related hypoglycaemia. A case report. Langenbecks Arch Surg. 2008;393(4):611-6.
17. Rikhof B, van Doorn J, Suurmeijer AJ, Rautenberg MW, Groenen PJ, Verdijk MA, et al. Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour. Ann Oncol. 2009;20(9):1582-1588. doi: 10.1093/annonc/mdp038
18. Rosenbaum JN, Lloyd RV. Pancreatic Neuroendocrine Neoplasms. Surg Pathol Clin. 2014;7(4):559-75. doi: 10.1016/j.path.2014.08.005